Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis

Autor: Büller, Hr, Destors, Jm, Gallus, A, Prins, Mh, Raskob, G, Charbonnier, B, Decousus, H, Leizorovicz, A, Laporte, S, Brandjes, Dp, Middeldorp, S, Pillion, G, Ceresetto, Jm, Hendler, H, Xavier, Dl, Santini, F, del Carmen Gallo, M, Coughlin, P, Chong, B, Leahy, M, Ward, C, Leyden, M, Prosser, I, Carroll, P, Gan, E, Mcrae, S, Salem, H, Pilger, E, Koppensteiner, R, Jurecka, W, Forstner, K, Hainaut, P, Motte, S, Vermassen, F, Araujo, Gr, Timi, Jr, Costa, Ja, Manenti, F, Yoshida, Wb, Kovacs, M, Delle Siega, A, Rodger, M, Miron, Mj, Anderson, D, Yeo, E, Kassis, J, Spacek, R, Klimsa, Z, Patek, F, Matoska, P, Maly, J, Srnsky, V, Cepelak, C, Nielsen, H, Noelsen, Hk, Avstrom, S, Husted, S, Tuxen, C, Stender, S, Azarian, R, Leftheriotis, G, Jego, P, Achkar, A, Zeltser, D, Keidar, S, Inbal, A, Piovella, F, Barone, M, Prandoni, Paolo, Imberti, D, Palaretti, G, Jerjes, C, Calvo, C, Van Marwijk Kooij, M, Timmerman, R, Mol, J, Ten Cate, H, Kamphuisen, P, Dullemond, A, Kroon, C, Veth, D, Biesma, D, Van Leendert, R, Ockelford, P, Chunilal, S, Szyber, P, Strzelczyk, J, Checinsli, P, Nizankowki, R, Cianciara, J, Kloczko, J, Tomkowski, W, Gutowski, P, Stupin, V, Sokurenko, G, Kirienko, A, Baesukov, A, Sokora, V, Katelnitsky, I, Didenko, Y, Lukianov, Y, Zatevakhin, I, Gavrilenko, A, Van Zyl LJ, Basson, Mm, Becker, Lh, Siebert, S, Engelbrecht, Jm, Otero, Dr, Paloma, Mj, del Toro, H, Kürşat Bozkurt, A, Joseph, S, Nadar, V, Baird, I, Han, D, Jacobson, A, Martin, J, Smith, D, Comerota, A, Guza, E, Wright, P.

Publikováno v: Journal of Thrombosis and Haemostasis, 9(1), 92-99. Wiley
Husted, S & Equinox Investigators 2011, ' Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis ', Journal of Thrombosis and Haemostasis, vol. 9, no. 1, pp. 92-9 . https://doi.org/10.1111/j.1538-7836.2010.04100.x
Journal of thrombosis and haemostasis, 9(1), 92-99. Wiley-Blackwell

Idraparinux, a long acting inhibitor of factor (F) Xa, is as effective as standard anticoagulant therapy for patients with symptomatic deep venous thrombosis. We investigated the potential use of the biotinylated molecule, idrabiotaparinux. Biotinyla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf262c41375d80a6079690bb4bde6aa8
https://doi.org/10.1111/j.1538-7836.2010.04100.x